These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 36558928)
1. Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets. Lee J; Park SB Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558928 [TBL] [Abstract][Full Text] [Related]
2. A Comparative Clinical Pharmacology Analysis of FDA-Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology. Ngo HX; Wen YW; Pisupati S; Huang W; Mandlekar S Clin Pharmacol Ther; 2024 Jul; ():. PubMed ID: 39072721 [TBL] [Abstract][Full Text] [Related]
3. Recent progress in covalent warheads for in vivo targeting of endogenous proteins. Shindo N; Ojida A Bioorg Med Chem; 2021 Oct; 47():116386. PubMed ID: 34509863 [TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Covalent Drug Discovery. Schaefer D; Cheng X Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242447 [TBL] [Abstract][Full Text] [Related]
7. Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics. Cheke RS; Kharkar PS Drug Dev Res; 2024 Feb; 85(1):e22132. PubMed ID: 38054744 [TBL] [Abstract][Full Text] [Related]
8. The Ascension of Targeted Covalent Inhibitors. Singh J J Med Chem; 2022 Apr; 65(8):5886-5901. PubMed ID: 35439421 [TBL] [Abstract][Full Text] [Related]
9. Covalent Inhibition in Drug Discovery. Ghosh AK; Samanta I; Mondal A; Liu WR ChemMedChem; 2019 May; 14(9):889-906. PubMed ID: 30816012 [TBL] [Abstract][Full Text] [Related]
10. New Electrophiles and Strategies for Mechanism-Based and Targeted Covalent Inhibitor Design. Ray S; Murkin AS Biochemistry; 2019 Dec; 58(52):5234-5244. PubMed ID: 30990686 [TBL] [Abstract][Full Text] [Related]
11. Nitriles: an attractive approach to the development of covalent inhibitors. Bonatto V; Lameiro RF; Rocho FR; Lameira J; Leitão A; Montanari CA RSC Med Chem; 2023 Feb; 14(2):201-217. PubMed ID: 36846367 [TBL] [Abstract][Full Text] [Related]
12. Targeted Covalent Inhibitors for Drug Design. Baillie TA Angew Chem Int Ed Engl; 2016 Oct; 55(43):13408-13421. PubMed ID: 27539547 [TBL] [Abstract][Full Text] [Related]
13. Recent applications of covalent chemistries in protein-protein interaction inhibitors. Chan AM; Goodis CC; Pommier EG; Fletcher S RSC Med Chem; 2022 Aug; 13(8):921-928. PubMed ID: 36092144 [TBL] [Abstract][Full Text] [Related]
14. Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update. Roskoski R Pharmacol Res; 2021 Mar; 165():105463. PubMed ID: 33513356 [TBL] [Abstract][Full Text] [Related]
15. 10 years into the resurgence of covalent drugs. De Vita E Future Med Chem; 2021 Jan; 13(2):193-210. PubMed ID: 33275063 [TBL] [Abstract][Full Text] [Related]
16. Covalent Inhibition in Drug Discovery: Filling the Void in Literature. Bjij I; Olotu FA; Agoni C; Adeniji E; Khan S; El Rashedy A; Cherqaoui D; Soliman MES Curr Top Med Chem; 2018; 18(13):1135-1145. PubMed ID: 30068277 [TBL] [Abstract][Full Text] [Related]
17. bioTCIs: Middle-to-Macro Biomolecular Targeted Covalent Inhibitors Possessing Both Semi-Permanent Drug Action and Stringent Target Specificity as Potential Antibody Replacements. Yang J; Tabuchi Y; Katsuki R; Taki M Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834935 [TBL] [Abstract][Full Text] [Related]
19. Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins. Yang Y; Shu YZ; Humphreys WG Chem Res Toxicol; 2016 Jan; 29(1):109-16. PubMed ID: 26675335 [TBL] [Abstract][Full Text] [Related]